DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Conrad Cairo Hotel

2024 年 11 月 25 日 6:00 下午 - 2024 年 11 月 27 日 6:00 下午

1191 Nile Corniche, Cairo, 11221, Egypt

Middle East and North Africa Conference (MENA)

Parallel Session 5A: Modernising the Regulatory Framework to Enable Efficient Lifecycle Management

Session Chair(s)

Melly  Lin, MS

Melly Lin, MS

CMC Regulatory Policy Lead, Pharma Technical Regulatory, F. Hoffmann-La Roche Ltd, Switzerland

May  Shawky Mohamed

May Shawky Mohamed

Regional Manager Regulatory Affairs MEAR, Merck Group, United Arab Emirates

This session will focus on recent updates regarding the modernisation of the regulatory framework to facilitate the timely approval of PACs (Post-Approval Changes), including EDA’ s experience in reliance implementation to the variations’ system. In addition, two case studies from industry will be shared regarding how to enhance the use of reliance and PACMP (Post Approval Change Management Protocol) to accelerate PAC approval. Regulators and industry will discuss how to optimise the LCM framework by leveraging the lessons learnt from case studies, opportunities for harmonisation with international guideline and including PACMP in the local guideline, with the ultimate goal of enabling fast approval of PACs and securing supply of medicines to patients.

Speaker(s)

Melly  Lin, MS

Melly Lin, MS

CMC Regulatory Policy Lead, Pharma Technical Regulatory, F. Hoffmann-La Roche Ltd, Switzerland

Introduction and Setting the Scene: EFPIA MERN Survey on PAC management system in Middle East and North Africa

Hebatullah  Ibrahim

Hebatullah Ibrahim

General Manager of biological Products General Administration, Egyptian Drug Authority (EDA), Egypt

EDA’s Experience - Reliance for Post-Approval Changes

Susanne  Ausborn, PHD

Susanne Ausborn, PHD

Global Head International Regulatory Policy, Roche, Switzerland

Case Study: Outcome of PAC Reliance Pilot with 48 countries

Ibrahim  Tlili, PHARMD, MPH, MSC

Ibrahim Tlili, PHARMD, MPH, MSC

Senior Scientist, International CMC EU/EEMEA, MSD, Switzerland

Case Study: Reliance and PACMPs to Accelerate a Major PAC Approval

Sumaya  Husain

Sumaya Husain

Clinical Trials Regulations Specialist, National Health Regulatory Authority (NHRA), Bahrain

Panel Discussion with Q and A, with the additional participation of:

Donia  Albastaki

Donia Albastaki

Acting Director, Pharmaceutical and Herbal Medicine Registration & Control Admin, Ministry of Health, State of Kuwait, Kuwait

Panel Discussion with Q and A, with the additional participation of:

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。